Outcome of patients with breast cancer in the oldest old (≥80 years).


Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 09 06 2019
revised: 11 11 2019
accepted: 12 11 2019
pubmed: 25 11 2019
medline: 13 11 2020
entrez: 25 11 2019
Statut: ppublish

Résumé

In the present study, we present a large institutional study to determine the influence of age≥ 80 years on breast cancer presentation and prognosis. The study is a retrospective analysis of our prospectively maintained breast cancer database study using data from of women managed from January 2007 through December 2013. Clinicopathologic characteristics were correlated with outcomes according to age (<80 years and ≥ 80 years). During the study period, 2083 women with invasive breast cancer were included of which 160 women aged ≥ 80 years (7.7 %). Overall survival was lower in the oldest old than in younger counterparts (p < 0.0001) as was distant metastasis free survival (p = 0.004). Differences in management included more radical surgeries and less chemotherapy and radiotherapy in case of age≥ 80 years. By multivariate analysis, age ≥ 80 years was an independent predictive factor of poor overall survival. In the present study, age ≥ 80 years was an independent predictive factor of poor overall survival.

Identifiants

pubmed: 31760264
pii: S0301-2115(19)30523-8
doi: 10.1016/j.ejogrb.2019.11.009
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

66-70

Informations de copyright

Copyright © 2019. Published by Elsevier B.V.

Auteurs

Claire Fleurier (C)

Gynecology Department, Centre Hospitalier Régional Universitaire de Tours, Hôpital Bretonneau, 2 boulevard Tonnellé, 37044 Tours, France; François Rabelais University, Faculté de Médecine de Tours, 10 boulevard Tonnellé, 37044 Tours, France.

Adeline De Wit (A)

Gynecology Department, Centre Hospitalier Régional Universitaire de Tours, Hôpital Bretonneau, 2 boulevard Tonnellé, 37044 Tours, France; François Rabelais University, Faculté de Médecine de Tours, 10 boulevard Tonnellé, 37044 Tours, France.

Joseph Pilloy (J)

Gynecology Department, Centre Hospitalier Régional Universitaire de Tours, Hôpital Bretonneau, 2 boulevard Tonnellé, 37044 Tours, France; François Rabelais University, Faculté de Médecine de Tours, 10 boulevard Tonnellé, 37044 Tours, France.

Laura Boivin (L)

Gynecology Department, Centre Hospitalier Régional Universitaire de Tours, Hôpital Bretonneau, 2 boulevard Tonnellé, 37044 Tours, France; François Rabelais University, Faculté de Médecine de Tours, 10 boulevard Tonnellé, 37044 Tours, France.

Marie-Lise Jourdan (ML)

INSERM UMR1069, 10 boulevard Tonnellé, 37044 Tours, France; Centre Hospitalier Régional Universitaire de Tours, Hôpital Bretonneau, 2 boulevard Tonnellé, 37044 Tours, France.

Flavie Arbion (F)

Histology Department, Centre Hospitalier Régional Universitaire de Tours, Hôpital Bretonneau, 2 boulevard Tonnellé, 37044 Tours, France.

Gilles Body (G)

Gynecology Department, Centre Hospitalier Régional Universitaire de Tours, Hôpital Bretonneau, 2 boulevard Tonnellé, 37044 Tours, France; François Rabelais University, Faculté de Médecine de Tours, 10 boulevard Tonnellé, 37044 Tours, France; INSERM UMR1069, 10 boulevard Tonnellé, 37044 Tours, France.

Lobna Ouldamer (L)

Gynecology Department, Centre Hospitalier Régional Universitaire de Tours, Hôpital Bretonneau, 2 boulevard Tonnellé, 37044 Tours, France; François Rabelais University, Faculté de Médecine de Tours, 10 boulevard Tonnellé, 37044 Tours, France; INSERM UMR1069, 10 boulevard Tonnellé, 37044 Tours, France. Electronic address: l.ouldamer@chu-tours.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH